Stock comparison
DexCom
Mettler-Toledo International
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
DXCM
DexCom
Market cap
$27.82B
Sector
Healthcare
MTD
Mettler-Toledo International
Market cap
$22.29B
Sector
Healthcare
Overall winner
Mettler-Toledo International MTD
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Fit scores by strategy
| Strategy | DXCM | MTD | Winner |
|---|---|---|---|
| Warren Buffett | 69B | 69B | Tie |
| Benjamin Graham | 74B | 65B | DXCM |
| Philip Fisher | 75B | 63C | DXCM |
| Peter Lynch | 61C | 66B | MTD |
| Joel Greenblatt | 58C | 68B | MTD |
| Charlie Munger | 66B | 74B | MTD |
| Terry Smith | 66B | 70B | MTD |
Side-by-side metrics
| Metric | DXCM | MTD |
|---|---|---|
| Market cap | $27.82B | $22.29B |
| P/E (TTM) | 24.6x | 25.3x |
| EV/EBIT | 25.4x | 21.6x |
| ROIC (TTM) | 18.03% | 36.09% |
| Gross margin | 61.84% | 57.79% |
| Net margin | 19.31% | 21.4% |
| Revenue CAGR 5y | 17.47% | 2.01% |
| EPS CAGR 5y | 39.82% | 6.12% |
| Debt / Equity | 0.5x | - |
| Dividend yield | 0.0% | 0.0% |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
DXCM leads on
- Revenue CAGR 5y17.47%vs 2.01%+88%
- EPS CAGR 5y39.82%vs 6.12%+85%
- Market cap$27.82Bvs $22.29B+20%
- Gross margin61.84%vs 57.79%+7%
MTD leads on
- Debt / Equity-vs 0.5x+101%
- ROIC (TTM)36.09%vs 18.03%+50%
- EV/EBIT21.6xvs 25.4x+15%
- Net margin21.4%vs 19.31%+10%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.